Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of rizatriptan in pediatric migraine
NCT01004263Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rizatriptan in migraine, sponsored by Organon & Co.. Started Dec 2009; status: completed.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01004263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004263.